A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer
NCT05235906
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
61
Enrollment
OTHER
Sponsor class
Conditions
Gastric Adenocarcinoma
Interventions
DRUG:
Surufatinib+Sintilimab
Sponsor
Sun Yat-sen University